Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease

Exp Neurol. 2008 Aug;212(2):548-51. doi: 10.1016/j.expneurol.2008.04.006. Epub 2008 Apr 15.

Abstract

Chronic reduction of the caloric intake is associated with extended lifespan, in rodents, and has been proposed to counteract neuronal loss in animal models of neurodegeneration. To test this hypothesis, we investigated the effect of dietary restriction (DR) in a rodent model of Parkinson's disease, based on the intrastriatal infusion of 6-hydroxydopamine. We could not confirm the neuroprotective effect of DR previously suggested: histological and behavioral measures indicated similar degrees of dopaminergic neuron loss in rats maintained on DR--for two or eight weeks prior to the lesion--or with free access to food.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Striatum / pathology*
  • Diet Therapy / methods*
  • Disease Models, Animal
  • Male
  • Nerve Degeneration / etiology
  • Nerve Degeneration / prevention & control*
  • Oxidopamine
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / complications*
  • Rats
  • Rats, Sprague-Dawley
  • Substantia Nigra / pathology*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Oxidopamine
  • Tyrosine 3-Monooxygenase